🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
0.68505
+0.0141 (2.09%)
At close: Nov 18, 2026, 4:00 PM EST
0.6797
-0.0054 (-0.78%)
After-hours: Nov 18, 2026, 4:45 PM EST

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2026, Radiopharm Theranostics had annual revenue of 12.87M AUD, down -1.05%. Radiopharm Theranostics had revenue of 6.66M in the half year ending June 30, 2026.

Revenue (ttm)
12.87M AUD
Revenue Growth
-1.05%
P/S Ratio
0.98
Revenue / Employee
918,938 AUD
Employees
14
Market Cap
8.74M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202612.87M-136.84K-1.05%
Jun 30, 202513.00M11.41M716.81%
Jun 30, 20241.59M-4.62M-74.37%
Jun 30, 20236.21M--
Jun 30, 2022---
Jun 30, 2021 Pro Pro Pro